Exploration on Molecular Mechanism of Reversal Effect of Compound Danshen Tablets on Hepatic Fibrosis Based on Network Pharmacology

Objective. To research the molecular mechanism of compound Danshen tablets in the treatment of hepatic fibrosis through network pharmacology. Methods. Traditional Chinese medicine systems pharmacology (TCMSP) and online Mendelian inheritance in man (OMIM) databases were searched for compound Danshen...

Full description

Saved in:
Bibliographic Details
Main Authors: Minling Cao, Jingyue Fan, Xiaoli Yang, Meifeng Shi, Shanshan Lin, Xiaoling Chi
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Applied Bionics and Biomechanics
Online Access:http://dx.doi.org/10.1155/2022/7241719
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832549236236877824
author Minling Cao
Jingyue Fan
Xiaoli Yang
Meifeng Shi
Shanshan Lin
Xiaoling Chi
author_facet Minling Cao
Jingyue Fan
Xiaoli Yang
Meifeng Shi
Shanshan Lin
Xiaoling Chi
author_sort Minling Cao
collection DOAJ
description Objective. To research the molecular mechanism of compound Danshen tablets in the treatment of hepatic fibrosis through network pharmacology. Methods. Traditional Chinese medicine systems pharmacology (TCMSP) and online Mendelian inheritance in man (OMIM) databases were searched for compound Danshen tablets’ active ingredients o and hepatic fibrosis-related genes. The network enrichment of the targets of “herb-compound-target” was visualized and analyzed using Cytoscape software. Then, the screened target genes were used to construct a protein-protein interaction network. The DAVID enrichment database (the database for annotation, visualization, and integrated discovery) was adopted for GO (Gene Ontology) enrichment and KEGG (Kyoto Encyclopedia of Genes and Genomes) pathway enrichment of vital nodes. Results. The results yielded 234 targets of compound Danshen tablets; ten important targets (TNF, IL-10, TGF-β1, EGF, CXCL16, CCL21, SERPINB5, SERPINA1, SOD2, and PPIG) for reversing hepatic fibrosis; and four core targets (TNF, IL-10, TGF-1, and EGF). In addition, KEGG enrichment analysis showed that compound Danshen tablets mainly involved FoxO and MAPK signaling pathways, as the key signaling pathways in the treatment of hepatic fibrosis. Conclusion. TNF, IL-10, TGF-1, and EGF and FOXO and MAPK signaling pathways play a key role in the pathogenesis of hepatic fibrosis. Based on the results of this study, the mechanism of action of compound Danshen tablets in the treatment of hepatic fibrosis may be associated with the regulation of FoxO and MAPK signaling pathways and inhibition of TNF, IL-10, TGF-1, and EGF.
format Article
id doaj-art-6d68b81750e547c380742d69b822d5ac
institution Kabale University
issn 1754-2103
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Applied Bionics and Biomechanics
spelling doaj-art-6d68b81750e547c380742d69b822d5ac2025-02-03T06:11:50ZengWileyApplied Bionics and Biomechanics1754-21032022-01-01202210.1155/2022/7241719Exploration on Molecular Mechanism of Reversal Effect of Compound Danshen Tablets on Hepatic Fibrosis Based on Network PharmacologyMinling Cao0Jingyue Fan1Xiaoli Yang2Meifeng Shi3Shanshan Lin4Xiaoling Chi5Department of HepatologyDepartment of HepatologyDepartment of HepatologyDepartment of HepatologyDepartment of HepatologyDepartment of HepatologyObjective. To research the molecular mechanism of compound Danshen tablets in the treatment of hepatic fibrosis through network pharmacology. Methods. Traditional Chinese medicine systems pharmacology (TCMSP) and online Mendelian inheritance in man (OMIM) databases were searched for compound Danshen tablets’ active ingredients o and hepatic fibrosis-related genes. The network enrichment of the targets of “herb-compound-target” was visualized and analyzed using Cytoscape software. Then, the screened target genes were used to construct a protein-protein interaction network. The DAVID enrichment database (the database for annotation, visualization, and integrated discovery) was adopted for GO (Gene Ontology) enrichment and KEGG (Kyoto Encyclopedia of Genes and Genomes) pathway enrichment of vital nodes. Results. The results yielded 234 targets of compound Danshen tablets; ten important targets (TNF, IL-10, TGF-β1, EGF, CXCL16, CCL21, SERPINB5, SERPINA1, SOD2, and PPIG) for reversing hepatic fibrosis; and four core targets (TNF, IL-10, TGF-1, and EGF). In addition, KEGG enrichment analysis showed that compound Danshen tablets mainly involved FoxO and MAPK signaling pathways, as the key signaling pathways in the treatment of hepatic fibrosis. Conclusion. TNF, IL-10, TGF-1, and EGF and FOXO and MAPK signaling pathways play a key role in the pathogenesis of hepatic fibrosis. Based on the results of this study, the mechanism of action of compound Danshen tablets in the treatment of hepatic fibrosis may be associated with the regulation of FoxO and MAPK signaling pathways and inhibition of TNF, IL-10, TGF-1, and EGF.http://dx.doi.org/10.1155/2022/7241719
spellingShingle Minling Cao
Jingyue Fan
Xiaoli Yang
Meifeng Shi
Shanshan Lin
Xiaoling Chi
Exploration on Molecular Mechanism of Reversal Effect of Compound Danshen Tablets on Hepatic Fibrosis Based on Network Pharmacology
Applied Bionics and Biomechanics
title Exploration on Molecular Mechanism of Reversal Effect of Compound Danshen Tablets on Hepatic Fibrosis Based on Network Pharmacology
title_full Exploration on Molecular Mechanism of Reversal Effect of Compound Danshen Tablets on Hepatic Fibrosis Based on Network Pharmacology
title_fullStr Exploration on Molecular Mechanism of Reversal Effect of Compound Danshen Tablets on Hepatic Fibrosis Based on Network Pharmacology
title_full_unstemmed Exploration on Molecular Mechanism of Reversal Effect of Compound Danshen Tablets on Hepatic Fibrosis Based on Network Pharmacology
title_short Exploration on Molecular Mechanism of Reversal Effect of Compound Danshen Tablets on Hepatic Fibrosis Based on Network Pharmacology
title_sort exploration on molecular mechanism of reversal effect of compound danshen tablets on hepatic fibrosis based on network pharmacology
url http://dx.doi.org/10.1155/2022/7241719
work_keys_str_mv AT minlingcao explorationonmolecularmechanismofreversaleffectofcompounddanshentabletsonhepaticfibrosisbasedonnetworkpharmacology
AT jingyuefan explorationonmolecularmechanismofreversaleffectofcompounddanshentabletsonhepaticfibrosisbasedonnetworkpharmacology
AT xiaoliyang explorationonmolecularmechanismofreversaleffectofcompounddanshentabletsonhepaticfibrosisbasedonnetworkpharmacology
AT meifengshi explorationonmolecularmechanismofreversaleffectofcompounddanshentabletsonhepaticfibrosisbasedonnetworkpharmacology
AT shanshanlin explorationonmolecularmechanismofreversaleffectofcompounddanshentabletsonhepaticfibrosisbasedonnetworkpharmacology
AT xiaolingchi explorationonmolecularmechanismofreversaleffectofcompounddanshentabletsonhepaticfibrosisbasedonnetworkpharmacology